ReP USP - Resultado da busca

Filtros : "Tauil, Carlos Bernardo" Removido: "FM" Limpar

Filtros

USP affiliated authors
- barreira, amilton antunes (~1)
- peron, jean pierre schatzmann (~1)
Date published
- 2022 (~1)
- 2015 (~1)
Subjects
- esclerose múltipla (2)
- adolescentes (1)
- covid-19 (1)
- crianças (1)
- doenças do nervo óptico (1)

Collaboration
Normalized affiliation
- universidade federal do rio de janeiro (ufrj) (~1)
Non normalized affiliation
- fundacão centro integrado de apoio a pessoa com deficiencia, joão pessoa, pb, brasil (1)
- hospital beneficencia portuguesa and hospital paulistano, sao paulo, sp (1)
- hospital beneficencia portuguesa de são paulo, são paulo, sp, brasil (1)
- hospital regional hans dieter schimidt, joinville, sc (1)
- hospital da restauracao de recife, recife, pe (1)

Artigo de periodico
New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19 (2022)
Fragoso, Yara Dadalti ; Gomes, Sidney ; Gonçalves, Marcus Vinicius Magno ; Mendes Junior, Euldes ; Oliveira, Bianca Etelvina S. de ; Rocha, Cristiane Franklin ; Santos, Gutemberg A. Cruz dos ; Tauil, Carlos Bernardo ; Araujo, Raquel Vassão ; Peron, Jean Pierre Schatzmann
Source: Multiple Sclerosis and Related Disorders. Unidade: ICB
Subjects: IMUNOLOGIA, ESCLEROSE MÚLTIPLA, DOENÇAS DO SISTEMA NERVOSO CENTRAL, NEUROMIELITE ÓPTICA, DOENÇAS DO NERVO ÓPTICO, VACINAS VIRAIS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRAGOSO, Yara Dadalti et al. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19. Multiple Sclerosis and Related Disorders, v. 57, p. 1-5, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.msard.2021.103321. Acesso em: 31 out. 2024.
APA
Fragoso, Y. D., Gomes, S., Gonçalves, M. V. M., Mendes Junior, E., Oliveira, B. E. S. de, Rocha, C. F., et al. (2022). New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19. Multiple Sclerosis and Related Disorders, 57, 1-5. doi:10.1016/j.msard.2021.103321
NLM
Fragoso YD, Gomes S, Gonçalves MVM, Mendes Junior E, Oliveira BES de, Rocha CF, Santos GAC dos, Tauil CB, Araujo RV, Peron JPS. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19 [Internet]. Multiple Sclerosis and Related Disorders. 2022 ; 57 1-5.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.msard.2021.103321
Vancouver
Fragoso YD, Gomes S, Gonçalves MVM, Mendes Junior E, Oliveira BES de, Rocha CF, Santos GAC dos, Tauil CB, Araujo RV, Peron JPS. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19 [Internet]. Multiple Sclerosis and Related Disorders. 2022 ; 57 1-5.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.msard.2021.103321
Artigo de periodico
Fingolimod prescribed for the treatment of multiple sclerosis in patients younger than age 18 years (2015)
Fragoso, Yara Dadalti; Alves-Leon, Soniza Vieira; Barreira, Amilton Antunes; Callegaro, Dagoberto; Ferreira, Maria Lucia Brito; Finkelsztejn, Alessandro; Gomes, Sidney; Gonçalves, Marcus Vinicius Magno; Machado, Maria Iris Moraes; Marques, Vanessa Daccach; Matta, Andre Palma Cunha; Papais-Alvarenga, Regina Maria; Pereira, Samira Luisa Apostolos; Tauil, Carlos Bernardo
Source: Pediatric Neurology. Unidade: FMRP
Subjects: ESCLEROSE MÚLTIPLA, CRIANÇAS, ADOLESCENTES, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRAGOSO, Yara Dadalti et al. Fingolimod prescribed for the treatment of multiple sclerosis in patients younger than age 18 years. Pediatric Neurology, v. 53, n. 2, p. 166-168, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.pediatrneurol.2015.03.024. Acesso em: 31 out. 2024.
APA
Fragoso, Y. D., Alves-Leon, S. V., Barreira, A. A., Callegaro, D., Ferreira, M. L. B., Finkelsztejn, A., et al. (2015). Fingolimod prescribed for the treatment of multiple sclerosis in patients younger than age 18 years. Pediatric Neurology, 53( 2), 166-168. doi:10.1016/j.pediatrneurol.2015.03.024
NLM
Fragoso YD, Alves-Leon SV, Barreira AA, Callegaro D, Ferreira MLB, Finkelsztejn A, Gomes S, Gonçalves MVM, Machado MIM, Marques VD, Matta APC, Papais-Alvarenga RM, Pereira SLA, Tauil CB. Fingolimod prescribed for the treatment of multiple sclerosis in patients younger than age 18 years [Internet]. Pediatric Neurology. 2015 ; 53( 2): 166-168.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.pediatrneurol.2015.03.024
Vancouver
Fragoso YD, Alves-Leon SV, Barreira AA, Callegaro D, Ferreira MLB, Finkelsztejn A, Gomes S, Gonçalves MVM, Machado MIM, Marques VD, Matta APC, Papais-Alvarenga RM, Pereira SLA, Tauil CB. Fingolimod prescribed for the treatment of multiple sclerosis in patients younger than age 18 years [Internet]. Pediatric Neurology. 2015 ; 53( 2): 166-168.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.pediatrneurol.2015.03.024

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024